Insmed INSM
NASDAQ INSM
$127.32 -1.48 (-1.15%)
As of: Sep 10, 2026 · 3:59 PM EDT

Insmed (INSM) Tax Provisions (2010 - 2026)

Insmed (INSM) posted Tax Provisions of $1.9 million for Q2 2026, up 26.67% on a QoQ basis from $1.5 million in Q1 2026, and up 52.86% year-over-year from $1.2 million in Q2 2025.

Analysis

Insmed (INSM) Tax Provisions (2010 - 2026) Analysis & Trends

Insmed has reported Tax Provisions for 16 years, with the latest figure at $1.9 million in Q2 2026.

  • On a quarterly basis, Tax Provisions rose 52.86% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $6.2 million, a 40.83% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 35.58% from the prior year.
  • Tax Provisions was $1.9 million for Q2 2026 at Insmed, up from $1.5 million in the prior quarter.
  • The five-year high for Tax Provisions was $1.9 million in Q2 2026, with the low at $100000.0 in Q4 2022.
  • Average Tax Provisions over 5 years is $894111.1, with a median of $875000.0 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Tax Provisions slipped 19.45% in 2022, then soared 900.0% in 2023.
  • Over 5 years, Tax Provisions stood at $100000.0 in 2022, then jumped by 900.0% to $1.0 million in 2023, then gained by 26.6% to $1.3 million in 2024, then gained by 20.54% to $1.5 million in 2025, then advanced by 24.51% to $1.9 million in 2026.
  • The last three Tax Provisions figures came in at $1.9 million (Q2 2026), $1.5 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 393.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 242.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 292.00 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 230.90 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -59.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 15.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 13.31 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 34.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -3.96 Mn
10 Insmed 27.67 Bn 26.51 Bn 358.27 Mn 1.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.90 Mn
Mar 31, 2026 1.50 Mn
Dec 31, 2025 1.53 Mn
Sep 30, 2025 1.32 Mn
Jun 30, 2025 1.24 Mn
Mar 31, 2025 912,000.00
Dec 31, 2024 1.27 Mn
Sep 30, 2024 1.01 Mn
Jun 30, 2024 838,000.00
Mar 31, 2024 600,000.00
Dec 31, 2023 1.00 Mn
Sep 30, 2023 544,000.00
Jun 30, 2023 530,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 501,000.00
Mar 31, 2022 400,000.00
Dec 31, 2021 -83,000.00
Sep 30, 2021 -2.60 Mn